Clinical outcome of patients with implantation of second‐generation drug‐eluting stents in the right coronary ostium: Insights from 2‐year follow‐up of the TWENTE trial

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 4, 2015-03 ,pp. : 524-531

John Wiley & Sons Inc

Access to resources Recommend Favorite

Distal Left Main Coronary Bifurcation Lesions Predict Worse Outcome in Patients Undergoing Percutaneous Implantation of Drug-Eluting Stents: Results from the Drug-Eluting Stent for the Treatment of Left Main Disease (DISTAL) Study

By  

Cardiology, Vol. 113, Iss. 4, 2009-02 ,pp. : 264-273

Karger

Access to resources Recommend Favorite

Safety and efficacy of a novel abluminal groove‐filled biodegradable polymer sirolimus‐eluting stent for the treatment of de novo coronary lesions: Two‐year results from a prospective patient‐level pooled analysis of TARGET trials

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. S1, 2015-03 ,pp. : 734-743

John Wiley & Sons Inc

Access to resources Recommend Favorite

Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial

By  

Cardiology, Vol. 137, Iss. 4, 2017-04 ,pp. : 207-217

Karger

Access to resources Recommend Favorite

Drug-Eluting Stents Compared with Bare Metal Stents Improve Late Outcome after Saphenous Vein Graft but Not after Large Native Vessel Interventions

By  

Cardiology, Vol. 112, Iss. 1, 2008-06 ,pp. : 49-55

Karger

Access to resources Recommend Favorite